come and gone, but the benefits of a growth year are likely to carry on for some time in San Diego. According to Connect, a non-profit group that supports innovation, they counted 446 technology and life science start-ups in 2014 up from 426 companies in 2013 (1). Of these firms, Bio-tech got 62% of the $805 million investment capital dollars while software and medical devices got a third and fourth place in total investment influx.
What does this say about San Diego? It says that San Diego has a budding bio-tech and software industry that should be supported by city policies, higher education, corporate training, and international promotion. Encouraging investment funds to find receptive companies seeking those investments for expansions puts money where it has the quickest and most efficient economic contribution.
The Economic contribution comes from using the investment money to expand operations, hire new people, and create additional contractual deals that grow not only the parent business but also smaller suppliers. Money invested into one company makes its way to other firms and the overall tax base of the city.
It is important for decision makers to look at their growing industries and find a connection between what their local competencies and resources offer to determine places to generate higher levels of investment growth. Making sure that the public is aware of these investments through various mediums that reach motivated investment entities helps in speeding up this growth process.
Economic expansion comes with the development of better city policies that further the growth of the area and better capitalizes on its local resources. Biotechnology and technology have significant international interest and is a field that is expected to grow in the future. Local military stakeholders may strengthen this industry, but the global market will determine the innovative value of its outputs. Getting companies and government to focus in the same area can mean higher levels of synergy.